SYRE vs JNJ: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc. and Johnson & Johnson in 2026
SYRE
Spyre Therapeutics Inc.
—
JNJ
Johnson & Johnson
$249.97
Key Metrics Comparison
| Metric | SYRE | JNJ | Winner |
|---|---|---|---|
| Market Cap | $7.60B | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze SYRE
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or JNJ a better investment?
Comparing SYRE and JNJ: Spyre Therapeutics Inc. has a market cap of $7.60B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and JNJ?
SYRE (Spyre Therapeutics Inc.) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or JNJ?
Both SYRE and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: SYRE or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: SYRE or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $7.60B for SYRE.
Should I buy SYRE or JNJ in 2026?
Both SYRE and JNJ have investment merit. SYRE trades at $N/A while JNJ trades at $249.97. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and JNJ stock?
Key differences: Market Cap ($7.60B vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy SYRE or JNJ in 2026?
The choice between SYRE and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between SYRE and JNJ?
SYRE (Spyre Therapeutics Inc.) has a market cap of $7.60B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.